ArticleCureus2025
Functional and Patient-Reported Outcomes of RegJoint™ Interpositional Arthroplasty for Thumb Carpometacarpal Joint (CMCJ) Arthritis: A Two-to-Five-Year Follow-Up Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/purpose This study aimed to assess the long-term outcomes of patients treated with RegJoint™ interpositional arthroplasty for thumb carpometacarpal joint (CMCJ) arthritis as a replacement to traditional practices after a follow-up period of two to five years (mean of 42 months). Methods A retrospective cohort study was conducted, which included 35 consecutive patients who underwent the RegJoint™ interpositional arthroplasty between 2017 and 2022 at the Department of Orthopaedics, South Warwickshire University NHS Foundation Trust, Warwickshire, Great Britain. Twenty-five patients were included in this study who met the inclusion and exclusion criteria and who agreed to participate in the study. Functional outcomes, including range of motion, quality of life, and patient satisfaction, were evaluated using standardised assessments such as the QuickDASH score and the Thumb Disability Examination (TDX) score. Results Among the 25 patients included in the study, the mean age was 62 years (range: 48-79 years), with a mean follow-up duration of 42 months (range: 24-60 months). The study demonstrated favourable postoperative outcomes, with a mean QuickDASH score of 15.8; some patients achieved complete symptom resolution. Notably, there were no reported cases of abnormal reactions, infections, or revisions within this cohort. Conclusion This long-term follow-up study demonstrates that RegJoint™ interpositional arthroplasty can be considered for patients with thumb CMCJ arthritis, given the good patient satisfaction and low complication rates. This technique provides a mean of alternative to traditional surgical techniques, particularly in patients wanting joint-preserving solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.